UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 49

Sortiert nach

Voriconazole plasma concentrations and dosing in paediatric patients below 24months of age

Mycoses, 2023-11, Vol.66 (11), p.969-976

2023

Volltextzugriff (PDF)

Clinical development of micafungin in children and neonates

Mycoses, 2012-04, Vol.55 (s1), p.39-45

2012

Volltextzugriff (PDF)

Posaconazole for paediatric patients: status of development and future perspectives

Mycoses, 2008-09, Vol.51 (s2), p.5-11

2008

Volltextzugriff (PDF)

Experiences with the use of caspofungin in paediatric patients

Mycoses, 2008-07, Vol.51 (s1), p.58-64

2008

Volltextzugriff (PDF)

New and emerging options for management of invasive fungal diseases in paediatric patients

Mycoses, 2024-01, Vol.67 (1), p.e13654-n/a

2024

Volltextzugriff (PDF)

Biomarker-based diagnostic work-up of invasive pulmonary aspergillosis in immunocompromised paediatric patients - is Aspergillus PCR appropriate?

Mycoses, 2016-02, Vol.59 (2), p.67-74

2016

Volltextzugriff (PDF)

Antifungal efficacy and pharmacodynamics of posaconazole in experimental models of invasive fungal infections

Mycoses, 2006-11, Vol.49 (s1), p.7-16

2006

Volltextzugriff (PDF)

Voriconazole plasma concentrations and dosing in paediatric patients below 24 months of age

Mycoses, 2023-11, Vol.66 (11), p.969-976

2023

Volltextzugriff (PDF)

Development of new strategies for early diagnosis of mucormycosis from bench to bedside

Mycoses, 2014-12, Vol.57 (s3), p.2-7

2014

Volltextzugriff (PDF)

Mucormycosis in paediatric patients: demographics, risk factors and outcome of 12 contemporary cases

Mycoses, 2011-11, Vol.54 (6), p.e785-e788

2011

Volltextzugriff (PDF)

Mucormycosis in paediatric patients: demographics, risk factors and outcome of 12 contemporary cases: Mucormycosis in paediatric patients

Mycoses, 2011-11, Vol.54 (6), p.e785-e788

2011

Volltextzugriff (PDF)

Invasive fungal infections in pediatric patients treated with tumor necrosis alpha (TNF‐α) inhibitors

Mycoses, 2017-04, Vol.60 (4), p.222-229

2017

Volltextzugriff (PDF)

Five-year-survey of invasive aspergillosis in a paediatric cancer centre. Epidemiology, management and long-term survival

Mycoses, 1999-09, Vol.42 (7-8), p.431-442

1999

Volltextzugriff (PDF)

Our 2014 approach to breakthrough invasive fungal infections

Mycoses, 2014-11, Vol.57 (11), p.645-651

2014

Volltextzugriff (PDF)

Epidemiology and outcomes of invasive fungal infections in allogeneic haematopoietic stem cell transplant recipients in the era of antifungal prophylaxis: a single-centre study with focus on emerging pathogens

Mycoses, 2015-06, Vol.58 (6), p.325-336

2015

Volltextzugriff (PDF)

Itraconazole - perspectives for the management of invasive aspergillosis

Mycoses, 2002-01, Vol.45 (S3), p.48-55

Groll, A. H.

2002

Volltextzugriff (PDF)

Differential effects of antifungal agents on expression of genes related to formation of Candida albicans biofilms

Mycoses, 2016-01, Vol.59 (1), p.43-47

2016

Volltextzugriff (PDF)

Prevalence of the reversed halo sign in neutropenic patients compared with non‐neutropenic patients: Data from a single‐centre study involving 27 patients with pulmonary mucormycosis (2003‐2016)

Mycoses, 2017-08, Vol.60 (8), p.526-533

2017

Volltextzugriff (PDF)

Immunotherapeutic strategies against mucormycosis in haematopoietic stem cell transplantation

Mycoses, 2014-12, Vol.57 (s3), p.8-12

2014

Volltextzugriff (PDF)

Fungal biomass is a key factor affecting polymorphonuclear leucocyte-induced hyphal damage of filamentous fungi

Mycoses, 2010-07, Vol.53 (4), p.321-328

2010

Volltextzugriff (PDF)

Comparative pharmacodynamic interaction analysis of triple combinations of caspofungin and voriconazole or ravuconazole with subinhibitory concentrations of amphotericin B against Aspergillus spp

Mycoses, 2010-05, Vol.53 (3), p.239-245

2010

Volltextzugriff (PDF)

Current practice of antifungal prophylaxis and treatment in immunocompromised children and adults with malignancies: a single centre approach

Mycoses, 2009-03, Vol.52 (2), p.107-117

2009

Volltextzugriff (PDF)

Deoxycholate amphotericin B and amphotericin B lipid complex exert additive antifungal activity in combination with pulmonary alveolar macrophages against Fusarium solani

Mycoses, 2006-03, Vol.49 (2), p.109-113

2006

Volltextzugriff (PDF)

Systematic review on efficacy and safety of empirical versus pre‐emptive antifungal therapy among children with febrile neutropenia reveals paucity of data

Mycoses, 2024-04, Vol.67 (4), p.e13722-n/a

2024

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Aktive Filter

KollektionEbook Central Perpetual and DDA

KollektionIngentaConnect Journals

KollektionNUS Single-Journal Subscriptions

Zeitschrift / SerieAngewandte Chemie International Edition

ThemaAnalysis

Zeitschrift / SerieMycoses

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(49)

Publikationsform

Artikel
(49)

Sprache

Englisch
(49)
Deutsch
(22)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Dermatology
(40)
Life Sciences & Biomedicine
(40)
Mycology
(40)
Science & Technology
(40)
Humans
(34)
Antifungal Agents - Therapeutic Use
(18)
Child
(15)
Female
(13)
Adolescent
(12)
Mycoses
(12)
Adult
(11)
Children
(11)
Male
(11)
Child, Preschool
(10)
Antifungal Agents - Pharmacology
(9)
Voriconazole
(9)
Mycoses - Drug Therapy
(8)
Pediatrics
(8)
Animals
(7)
Aspergillus
(7)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Menü

Weitere Dienste

Einstellungen

Voriconazole plasma concentrations and dosing in paediatric patients below 24months of age

Clinical development of micafungin in children and neonates

Posaconazole for paediatric patients: status of development and future perspectives

Experiences with the use of caspofungin in paediatric patients

New and emerging options for management of invasive fungal diseases in paediatric patients

Biomarker-based diagnostic work-up of invasive pulmonary aspergillosis in immunocompromised paediatric patients - is Aspergillus PCR appropriate?

Antifungal efficacy and pharmacodynamics of posaconazole in experimental models of invasive fungal infections

Voriconazole plasma concentrations and dosing in paediatric patients below 24 months of age

Development of new strategies for early diagnosis of mucormycosis from bench to bedside

State of Medical Mycology at German Academic Medical Centres: A Survey of the German‐Speaking Mycological Society (DMYKG) and the Paul‐Ehrlich‐Society for Chemotherapy (PEG)

Mucormycosis in paediatric patients: demographics, risk factors and outcome of 12 contemporary cases

Mucormycosis in paediatric patients: demographics, risk factors and outcome of 12 contemporary cases: Mucormycosis in paediatric patients

Invasive fungal infections in pediatric patients treated with tumor necrosis alpha (TNF‐α) inhibitors

Five-year-survey of invasive aspergillosis in a paediatric cancer centre. Epidemiology, management and long-term survival

Our 2014 approach to breakthrough invasive fungal infections

Epidemiology and outcomes of invasive fungal infections in allogeneic haematopoietic stem cell transplant recipients in the era of antifungal prophylaxis: a single-centre study with focus on emerging pathogens

Itraconazole - perspectives for the management of invasive aspergillosis

Differential effects of antifungal agents on expression of genes related to formation of Candida albicans biofilms

Prevalence of the reversed halo sign in neutropenic patients compared with non‐neutropenic patients: Data from a single‐centre study involving 27 patients with pulmonary mucormycosis (2003‐2016)

Immunotherapeutic strategies against mucormycosis in haematopoietic stem cell transplantation

Fungal biomass is a key factor affecting polymorphonuclear leucocyte-induced hyphal damage of filamentous fungi

Comparative pharmacodynamic interaction analysis of triple combinations of caspofungin and voriconazole or ravuconazole with subinhibitory concentrations of amphotericin B against Aspergillus spp

Current practice of antifungal prophylaxis and treatment in immunocompromised children and adults with malignancies: a single centre approach

Deoxycholate amphotericin B and amphotericin B lipid complex exert additive antifungal activity in combination with pulmonary alveolar macrophages against Fusarium solani

Systematic review on efficacy and safety of empirical versus pre‐emptive antifungal therapy among children with febrile neutropenia reveals paucity of data

Aktive Filter

Suchergebnisse filtern